|
|
||||||||



*
Department of Pharmacology and Cell Biophysics, University of Cincinnati College of Medicine, Cincinnati, OH 45267; and
GenPharm International, San Jose, CA 95131
Fab preparations of sheep polyclonal anti-digoxin Abs have
proven useful for reversal of the toxic effects of digoxin overdoses in
patients. Unfortunately, the use of foreign species proteins in humans
is limited because of the potential for immunological responses that
include hypersensitivity reactions and acute anaphylaxis. Immunization
of recently developed transgenic mice, whose endogenous µ heavy and
light chain Ig genes are inactivated and which carry human Ig gene
segments, with a digoxin-protein conjugate has enabled us to generate
and isolate eight hybridoma cell lines secreting human sequence
anti-digoxin mAbs. Six of the mAbs have been partially
characterized and shown to have high specificity and low nanomolar
affinities for digoxin. In addition, detailed competition binding
studies performed with three of these mAbs have shown them to have
distinct differences in their digoxin binding, and that all three
structural moieties of the drug, the primary digitoxose sugar, steroid,
and five-member unsaturated lactone ring, contribute to Ab
recognition.
This article has been cited by other articles:
![]() |
A. B. Norman, M. R. Tabet, M. K. Norman, W. R. Buesing, A. J. Pesce, and W. J. Ball A Chimeric Human/Murine Anticocaine Monoclonal Antibody Inhibits the Distribution of Cocaine to the Brain in Mice J. Pharmacol. Exp. Ther., January 1, 2007; 320(1): 145 - 153. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |